Cargando…

PRR14 acts a novel oncogene activating the PI3K signal pathway in human cutaneous squamous cell carcinoma

Proline rich protein 14 (PRR14) is considered as a new component of the nuclear fiber layer, it may be a key molecule in mediating nuclear morphological changes and functional changes in tumorigenesis. But, it's still unclear in human cutaneous squamous cell carcinoma (cSCC). In the study, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Lili, Yang, Jie, Ji, Zhoujing, Zhang, Jie, Yang, Shengju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266252/ https://www.ncbi.nlm.nih.gov/pubmed/37325059 http://dx.doi.org/10.7150/jca.83695

Ejemplares similares

Oncogene PRR14 promotes breast cancer through activation of PI3K signal pathway and inhibition of CHEK2 pathway
por: Ren, Xiaolei, et al.
Publicado: (2020)

LINC00467 induces melanoma deterioration by targeting miR-485-5p/p21 activated kinase 1
por: Ji, Zhoujing, et al.
Publicado: (2023)

The oncogenic potential of PRR11 gene in Tongue Squamous Cell Carcinoma cells
por: Wang, Chunyang, et al.
Publicado: (2019)

Discovery of a novel target for cancer: PRR14
por: Xiao, Shaowen, et al.
Publicado: (2016)

AKR1C2 acts as a targetable oncogene in esophageal squamous cell carcinoma via activating PI3K/AKT signaling pathway
por: Zhang, Zhan‐Fei, et al.
Publicado: (2020)

A novel role of PRR14 in the regulation of skeletal myogenesis
por: Yang, M, et al.
Publicado: (2015)

PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer
por: Song, Zongchang, et al.
Publicado: (2015)

The prognostic potential and oncogenic effects of PRR11 expression in hilar cholangiocarcinoma
por: Chen, Ying, et al.
Publicado: (2015)

PRR14 organizes H3K9me3-modified heterochromatin at the nuclear lamina
por: Kiseleva, Anna A., et al.
Publicado: (2023)

Increased PRR14 and VCAM-1 level in serum of patients with Parkinson's disease
por: Zheng, Huimin, et al.
Publicado: (2022)

Inhibition of Oncogenic Src Ameliorates Silica-Induced Pulmonary Fibrosis via PI3K/AKT Pathway
por: Hao, Xiaohui, et al.
Publicado: (2023)

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma
por: Hu, Ankang, et al.
Publicado: (2023)

PRR14 overexpression promotes cell growth, epithelial to mesenchymal transition and metastasis of colon cancer via the AKT pathway
por: Li, Fangfang, et al.
Publicado: (2019)

Overexpression of PRR11 promotes tumorigenic capability and is associated with progression in esophageal squamous cell carcinoma
por: Zhou, Li, et al.
Publicado: (2019)

MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling
por: Shen, Qiushuo, et al.
Publicado: (2022)

Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer
por: Lee, Kyung-min, et al.
Publicado: (2020)

Rab14 Act as Oncogene and Induce Proliferation of Gastric Cancer Cells via AKT Signaling Pathway
por: Guo, Bo, et al.
Publicado: (2017)

(Pro)renin receptor involves in myocardial fibrosis and oxidative stress in diabetic cardiomyopathy via the PRR–YAP pathway
por: Yu, Shiran, et al.
Publicado: (2021)

A Dual PI3K/HDAC Inhibitor Downregulates Oncogenic Pathways in Hematologic Tumors In Vitro and In Vivo
por: Yan, Zheng, et al.
Publicado: (2021)

NGF Accelerates Cutaneous Wound Healing by Promoting the Migration of Dermal Fibroblasts via the PI3K/Akt-Rac1-JNK and ERK Pathways
por: Chen, Ji-Cai, et al.
Publicado: (2014)

SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma
por: Yang, Yu-Feng, et al.
Publicado: (2018)

HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas
por: Sun, Yiyun, et al.
Publicado: (2021)

The PRR14 heterochromatin tether encodes modular domains that mediate and regulate nuclear lamina targeting
por: Dunlevy, Kelly L., et al.
Publicado: (2020)

Oncogenic transmembrane protein 158 drives the PI3K/Akt signaling pathway to accelerate gastric cancer cell growth
por: Cui, Xiaoting, et al.
Publicado: (2023)

HOXB7 acts as an oncogenic biomarker in head and neck squamous cell carcinoma
por: Wu, Xiang, et al.
Publicado: (2021)

14-3-3γ Induces Oncogenic Transformation by Stimulating MAP Kinase and PI3K Signaling
por: Radhakrishnan, Vijayababu M., et al.
Publicado: (2010)

Pseudo-Response Regulator (PRR) Homologues of the Moss Physcomitrella patens: Insights into the Evolution of the PRR Family in Land Plants
por: Satbhai, Santosh B., et al.
Publicado: (2011)

PRR11 and SKA2 promote the proliferation, migration and invasion of esophageal carcinoma cells
por: Chen, Jie, et al.
Publicado: (2020)

Effects of (Pro)renin Receptor on Diabetic Cardiomyopathy Pathological Processes in Rats via the PRR-AMPK-YAP Pathway
por: Xiong, Jie, et al.
Publicado: (2021)

High mobility group box 1 regulates tumor metastasis in cutaneous squamous cell carcinoma via the PI3K/AKT and MAPK signaling pathways
por: SUN, YING, et al.
Publicado: (2016)

The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma
por: Saito, Norihiko, et al.
Publicado: (2019)

Diuretic Action of Apelin-13 Mediated by Inhibiting cAMP/PKA/sPRR Pathway
por: Chen, Yanting, et al.
Publicado: (2021)

Roles of PRR-Mediated Signaling Pathways in the Regulation of Oxidative Stress and Inflammatory Diseases
por: Li, Pengwei, et al.
Publicado: (2021)

CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
por: Zhang, Li Q., et al.
Publicado: (2019)

MOB kinase activator 1A acts as an oncogene by targeting PI3K/AKT/mTOR in ovarian cancer
por: Lei, Jian, et al.
Publicado: (2023)

PRR7-AS1 Correlates with Immune Cell Infiltration and Is a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: Lu, Yifan, et al.
Publicado: (2022)

Cancer: A Tale of Aberrant PRR Response
por: Nagi, Raunaq Singh, et al.
Publicado: (2014)

MicroRNA-26b-5p suppresses the proliferation of tongue squamous cell carcinoma via targeting proline rich 11 (PRR11)
por: Yi, Liang, et al.
Publicado: (2021)

Long noncoding RNA–mediated activation of PROTOR1/PRR5-AKT signaling shunt downstream of PI3K in triple-negative breast cancer
por: Tu, Zhenbo, et al.
Publicado: (2022)

Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses
por: Vasou, Andri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ilk0ap6t15gjqbd011vhfrhsba